Wegovy Doses: Finding the Right One for You

What Doses Are Available?

Wegovy comes in five dose levels, each as a once-weekly injection using a prefilled pen: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg. The standard approach from the STEP clinical trials is to start at 0.25 mg and increase every four weeks, stepping through each level until you reach the 2.4 mg target dose.

That escalation ladder looks like this:

The 1.7 mg and 2.4 mg doses are the "obesity-specific" higher levels that go beyond the 0.25 to 1.0 mg range used in diabetes formulations.

Does the Dose Really Matter for Results?

Yes, and the pattern is consistent. In the pivotal STEP trials, the 2.4 mg dose was chosen as the target because higher doses produced greater weight loss in a clear dose-response pattern without major additional side effects. Early phase 2 research confirmed the same thing: bigger doses led to markedly larger weight losses with acceptable tolerability.

To put numbers on it: in STEP 1, people taking 2.4 mg weekly alongside lifestyle changes lost 14.9% of their body weight over 68 weeks, compared to just 2.4% with placebo. The STEP 5 trial showed that result held up over two full years, with 15.2% weight loss versus 2.6% for placebo at 104 weeks.

Beyond weight, the SELECT trial followed over 17,600 people with cardiovascular disease for roughly four years and found that semaglutide 2.4 mg reduced major cardiovascular events by 20% and sustained about 10.2% weight loss over the entire study period. So the benefits extend well past the number on the scale.

What If the Side Effects Are Rough?

This is where real life diverges from the clinical trial playbook. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. A multidisciplinary expert consensus on managing GLP-1 side effects recommends a "start low, go slow" approach with built-in flexibility. Their specific guidance:

• If GI symptoms hit while you're escalating, extend your current dose for an extra 2 to 4 weeks before moving up.
• Do not increase your dose while significant symptoms are still present.
• If symptoms appear at a new higher dose, drop back to the previous dose, stabilize, and then try increasing more gradually.
• If you cannot tolerate the full 2.4 mg, accept a lower maintenance dose rather than forcing the maximum.
• A temporary pause with a later restart is reasonable if symptoms are severe.
• If you've needed anti-nausea or GI medications for more than a month at a stable dose, consider reducing the Wegovy dose.

The core principle is that tolerability matters as much as the target. A dose you can actually stay on long-term beats a higher dose that makes you quit.

What Happens If I Stop Taking It?

The evidence here is sobering and consistent. In the STEP 4 trial, all participants first lost about 10.6% of their body weight over 20 weeks on semaglutide. They were then split into two groups: one continued the drug, and the other switched to placebo. Over the next 48 weeks, the group that kept taking semaglutide lost an additional 7.9%, while the group that stopped regained 6.9%. Waist circumference, blood pressure, and physical functioning all improved further with continued treatment versus placebo.

In the STEP 1 extension study, people who stopped both the drug and the lifestyle program regained about two-thirds of the weight they had lost within one year, ending up only 5.6% below where they started. Cardiometabolic benefits drifted back toward baseline too.

The takeaway is that, for many people, the weight and health benefits of Wegovy depend on continuing the medication.

Can Lifestyle Changes Protect You If You Stop?

They help, but they don't fully prevent regain. A large VA analysis found that people who combined semaglutide with a structured lifestyle program kept more of their weight loss after discontinuation than those without a program (5.8% net loss at 12 months off-drug versus 3.3%). A liraglutide trial (a related GLP-1 drug) showed that people who had combined exercise with the medication maintained more weight loss one year after stopping than those on the drug alone, though some regain still occurred.

So strong habits do provide a meaningful buffer. But current data suggest most people still regain weight when they stop the medication, even with good lifestyle practices in place.

Is It Worth Trying a Lower Maintenance Dose Once You Hit Your Goal?

This is one of the most practical questions people have, and the honest answer is that it's under-studied. No large trials have directly tested a step-down protocol (for example, going from 2.4 mg to 1.7 mg to 1.0 mg) after someone reaches their goal weight.

We know from real-world data that many people stay on 1.0 mg long-term, but the consequences for weight maintenance at lower doses haven't been rigorously measured. The evidence overall supports treating obesity with semaglutide as long-term, possibly lifelong therapy rather than a short course.

That said, expert guidance and trial data suggest a reasonable middle path: titrate down to the lowest dose that maintains your weight and metabolic markers, but treat it as an experiment with close follow-up. Track your weight, waist circumference, blood pressure, and lab work, and be ready to increase the dose again if things start sliding.

What Can You Actually Do With This Information?

Your situation falls somewhere along a spectrum, and the research supports matching your strategy to it:

• If you're tolerating the drug well and can afford it, the strongest evidence supports aiming for the 2.4 mg target. This dose produced the largest weight loss, the longest-sustained benefits over two and four years, and the cardiovascular risk reduction seen in the SELECT trial.
• If side effects are making life miserable, slow down. The expert consensus is clear: extend each dose step by 2 to 4 weeks, drop back if needed, and accept a lower maintenance dose rather than quitting altogether. A dose of 1.0 or 1.7 mg that you can sustain beats a 2.4 mg dose that drives you off the medication.
• If you're thinking about stopping, proceed with eyes open. The research strongly suggests you will regain a significant portion of lost weight. Lifestyle changes help soften the regain, but they don't prevent it entirely. If you do try stepping down or stopping, do it with your doctor's guidance, monitor your numbers closely, and have a plan to restart if needed.

The most important insight from this body of research might be the simplest: the best Wegovy dose is the one you can take consistently, for a long time. Getting there is worth the patience.